SOD1 and amyotrophic lateral sclerosis: We indeed found NPY to be increased in CSF of SOD1‐ALS patients in comparison to controls, which is line with previous work describing increased NPY in human post‐mortem ALS samples and revealing that antagonism of the Y1 receptor is sufficient to rescue motor phenotypes in a murine model of ALS.53